In Brief

House Energy and Commerce Committee Democratic leaders urge FDA to advance clinical trial diversity efforts

Energy and Commerce Committee Health Subcommittee Ranking Member Rep. Anna G. Eshoo (D-CA), Ranking Member Rep. Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Rep. Kathy Castor (D-FL) wrote to FDA Commissioner Robert M. Califf to urge the agency to move forward with guidance to improve the diversity of populations represented in clinical trials.
University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center
Black History MonthConversation with The Cancer Letter

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center

A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center.
In Brief

Rady Children’s oncologist Paula Aristizabal receives $4M to diversify clinical trials participation

Paula Aristizabal, a pediatric oncologist at Rady Children’s Hospital-San Diego and associate professor of pediatrics in pediatric hematology/oncology at the University of California San Diego and Moores Cancer Center, received a $4 million R01 research grant to expand a pilot program aimed at improving diverse participation in pediatric cancer clinical trials.